Engineered Mesenchymal Stem Cells for Targeting Solid Tumors: Therapeutic Potential beyond Regenerative Therapy

Area of Science:

• Biomedical Engineering
• Cancer Therapeutics
• Regenerative Medicine

Background:

• Mesenchymal stem cells (MSCs) possess regenerative potential and tumor-homing capabilities.
• MSCs are explored as cellular vehicles for targeted cancer therapy.
• Previous efforts focused on genetically modified MSCs for protein delivery, facing drug load capacity limitations.

Purpose of the Study:

• To review strategies for non-genetically modifying MSCs.
• To enhance MSCs for targeted delivery of small molecule chemotherapeutic agents.
• To overcome limitations in using MSCs as drug delivery vehicles.

Main Methods:

• Discussion of various non-genetic modification strategies for MSCs.
• Exploitation of MSCs' inherent tumor-tropic and drug-resistant properties.
• Focus on optimizing MSC engineering for drug delivery.

Main Results:

• Non-genetic modifications offer a viable approach for MSC-based drug delivery.
• Enhanced MSCs can improve the targeted delivery of chemotherapeutic agents.
• Addressing molecular mechanisms of tumor tropism is key for efficacy.

Conclusions:

• Non-genetic modification of MSCs is a promising strategy for targeted cancer chemotherapy.
• Optimizing MSCs as drug delivery vehicles requires further research into tumor tropism mechanisms.
• MSCs' inherent properties make them suitable carriers for cytotoxic payloads.